Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

[When to operate Crohn's disease patients with ileocaecal manifestation ?]

Nowacki TM, Bettenworth D.

Z Gastroenterol. 2018 Feb;56(2):165-167. doi: 10.1055/s-0043-121718. Epub 2018 Feb 7. German. No abstract available.

PMID:
29415315
2.

Validation of the "United Registries for Clinical Assessment and Research" (UR-CARE), a European online registry for clinical care and research in Inflammatory Bowel Disease.

Burisch J, Gisbert JP, Siegmund B, Bettenworth D, Bohn Thomsen S, Cleynen I, Cremer A, Ding NJS, Furfaro F, Galanopoulos M, Grunert PC, Hanzel J, Knezevic Ivanovski T, Krustins E, Noor N, O'Morain N, Rodríguez-Lago I, Scharl M, Tua J, Uzzan M, Yassin NA, Baert F, Langholz E.

J Crohns Colitis. 2018 Feb 3. doi: 10.1093/ecco-jcc/jjy015. [Epub ahead of print]

PMID:
29415255
3.

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation.

Nowacki TM, Bettenworth D, Brückner M, Cordes F, Lenze F, Becker A, Wildgruber M, Eisenblätter M.

J Vis Exp. 2017 Dec 15;(130). doi: 10.3791/55942.

PMID:
29286467
4.

Targeting Mucosal Endothelin-A-Receptor Expression by Fluorescence Endoscopy is Feasible to Detect and Characterize Colitis-Associated Cancer in Mice.

Mücke MM, Bettenworth D, Geyer C, Schwegmann K, Poremba C, Schäfers M, Domagk D, Höltke C, Lenz P.

Inflamm Bowel Dis. 2017 Dec 19;24(1):111-122. doi: 10.1093/ibd/izx032.

PMID:
29272493
5.

Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F; European Crohn’s and Colitis Organisation [ECCO].

J Crohns Colitis. 2017 Dec 4;11(12):1512. doi: 10.1093/ecco-jcc/jjx105. No abstract available.

PMID:
29088340
6.

Quantitative phase microscopy for evaluation of intestinal inflammation and wound healing utilizing label-free biophysical markers.

Bettenworth D, Bokemeyer A, Poremba C, Ding NS, Ketelhut S, Lenz P, Kemper B.

Histol Histopathol. 2017 Oct 9:11937. doi: 10.14670/HH-11-937. [Epub ahead of print] Review.

PMID:
28990642
7.

Circadian rhythm disruption impairs tissue homeostasis and exacerbates chronic inflammation in the intestine.

Pagel R, Bär F, Schröder T, Sünderhauf A, Künstner A, Ibrahim SM, Autenrieth SE, Kalies K, König P, Tsang AH, Bettenworth D, Divanovic S, Lehnert H, Fellermann K, Oster H, Derer S, Sina C.

FASEB J. 2017 Nov;31(11):4707-4719. doi: 10.1096/fj.201700141RR. Epub 2017 Jul 14.

PMID:
28710114
8.

Detection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasound.

Brückner M, Heidemann J, Nowacki TM, Cordes F, Stypmann J, Lenz P, Gohar F, Lügering A, Bettenworth D.

World J Gastroenterol. 2017 Apr 28;23(16):2899-2911. doi: 10.3748/wjg.v23.i16.2899.

9.

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F; European Crohn’s and Colitis Organisation [ECCO].

J Crohns Colitis. 2017 Jul 1;11(7):769-784. doi: 10.1093/ecco-jcc/jjx009. No abstract available.

PMID:
28513805
10.

Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication.

Bettenworth D, Rieder F.

Dig Dis. 2017;35(1-2):25-31. doi: 10.1159/000449079. Epub 2017 Feb 1. Review.

PMID:
28147352
11.

Diagnosis and treatment of anemia in patients with inflammatory bowel disease.

Mücke V, Mücke MM, Raine T, Bettenworth D.

Ann Gastroenterol. 2017;30(1):15-22. doi: 10.20524/aog.2016.0083. Epub 2016 Sep 6. Review.

12.

A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn's Disease.

Bettenworth D, Gustavsson A, Atreja A, Lopez R, Tysk C, van Assche G, Rieder F.

Inflamm Bowel Dis. 2017 Jan;23(1):133-142. doi: 10.1097/MIB.0000000000000988. Review.

PMID:
28002130
13.

[Evolution of clinical trial design investigating biological therapies in patients with inflammatory bowel disease - implications for clinical practice].

Bettenworth D.

Z Gastroenterol. 2017 Mar;55(3):304-306. doi: 10.1055/s-0042-120439. Epub 2016 Dec 5. German. No abstract available.

PMID:
27919109
14.

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing.

Lenz P, Brückner M, Ketelhut S, Heidemann J, Kemper B, Bettenworth D.

J Vis Exp. 2016 Sep 13;(115). doi: 10.3791/54460.

PMID:
27685659
15.

MicroRNA-320a Strengthens Intestinal Barrier Function and Follows the Course of Experimental Colitis.

Cordes F, Brückner M, Lenz P, Veltman K, Glauben R, Siegmund B, Hengst K, Schmidt MA, Cichon C, Bettenworth D.

Inflamm Bowel Dis. 2016 Oct;22(10):2341-55. doi: 10.1097/MIB.0000000000000917.

PMID:
27607334
16.

The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration.

Nowacki TM, Remaley AT, Bettenworth D, Eisenblätter M, Vowinkel T, Becker F, Vogl T, Roth J, Tietge UJ, Lügering A, Heidemann J, Nofer JR.

Br J Pharmacol. 2016 Sep;173(18):2780-92. doi: 10.1111/bph.13556. Epub 2016 Aug 11.

17.

Endoscopy-guided orthotopic implantation of colorectal cancer cells results in metastatic colorectal cancer in mice.

Bettenworth D, Mücke MM, Schwegmann K, Faust A, Poremba C, Schäfers M, Domagk D, Lenz P.

Clin Exp Metastasis. 2016 Aug;33(6):551-62. doi: 10.1007/s10585-016-9797-7. Epub 2016 May 4.

PMID:
27146063
18.

European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease.

Rieder F, Latella G, Magro F, Yuksel ES, Higgins PD, Di Sabatino A, de Bruyn JR, Rimola J, Brito J, Bettenworth D, van Assche G, Bemelman W, d'Hoore A, Pellino G, Dignass AU.

J Crohns Colitis. 2016 Aug;10(8):873-85. doi: 10.1093/ecco-jcc/jjw055. Epub 2016 Feb 29.

PMID:
26928961
19.

Solving a disaster following coronary bypass operation.

Neumann PA, Laukoetter M, Mennigen R, Kebschull L, Bettenworth D, Lenze F, Ullerich H, Senninger N, Vowinkel T.

Gut. 2016 Oct;65(10):1601. doi: 10.1136/gutjnl-2015-311233. Epub 2016 Feb 17. No abstract available.

PMID:
26887817
20.

Heterogeneity in endoscopic treatment of Crohn's disease-associated strictures: An international inflammatory bowel disease specialist survey.

Bettenworth D, Lopez R, Hindryckx P, Levesque BG, Rieder F.

J Gastroenterol. 2016 Oct;51(10):939-48. doi: 10.1007/s00535-016-1172-6. Epub 2016 Jan 30.

PMID:
26831355
21.

Assessment of stricturing Crohn's disease: Current clinical practice and future avenues.

Bettenworth D, Nowacki TM, Cordes F, Buerke B, Lenze F.

World J Gastroenterol. 2016 Jan 21;22(3):1008-16. doi: 10.3748/wjg.v22.i3.1008. Review.

22.

Diagnostic imaging advances in murine models of colitis.

Brückner M, Lenz P, Mücke MM, Gohar F, Willeke P, Domagk D, Bettenworth D.

World J Gastroenterol. 2016 Jan 21;22(3):996-1007. doi: 10.3748/wjg.v22.i3.996. Review.

23.

Reversibility of Stricturing Crohn's Disease-Fact or Fiction?

Bettenworth D, Rieder F.

Inflamm Bowel Dis. 2016 Jan;22(1):241-7. doi: 10.1097/MIB.0000000000000598. Review.

24.

Detection of Early Murine Colorectal Cancer by MMP-2/-9-Guided Fluorescence Endoscopy.

Schwegmann K, Bettenworth D, Hermann S, Faust A, Poremba C, Foell D, Schäfers M, Domagk D, Lenz P.

Inflamm Bowel Dis. 2016 Jan;22(1):82-91. doi: 10.1097/MIB.0000000000000605.

PMID:
26457379
25.

[Management of Crohn's disease after intestinal resection].

Bettenworth D, Dignass A.

Z Gastroenterol. 2015 Aug;53(8):843-5. doi: 10.1055/s-0035-1553396. Epub 2015 Aug 18. German. No abstract available.

PMID:
26284331
26.

Reprogramming of monocytes by GM-CSF contributes to regulatory immune functions during intestinal inflammation.

Däbritz J, Weinhage T, Varga G, Wirth T, Walscheid K, Brockhausen A, Schwarzmaier D, Brückner M, Ross M, Bettenworth D, Roth J, Ehrchen JM, Foell D.

J Immunol. 2015 Mar 1;194(5):2424-38. doi: 10.4049/jimmunol.1401482. Epub 2015 Feb 4.

27.

European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases.

Dignass AU, Gasche C, Bettenworth D, Birgegård G, Danese S, Gisbert JP, Gomollon F, Iqbal T, Katsanos K, Koutroubakis I, Magro F, Savoye G, Stein J, Vavricka S; European Crohn’s and Colitis Organisation [ECCO].

J Crohns Colitis. 2015 Mar;9(3):211-22. doi: 10.1093/ecco-jcc/jju009. Epub 2014 Dec 3. No abstract available.

PMID:
25518052
28.

Giant cell arteritis exclusively detected by 18F-fluorodeoxyglucose positron emission tomography: a case report.

Brückner M, Bettenworth D, Hengst K, Weckesser M, Willeke P, Heidemann J.

J Med Case Rep. 2014 Oct 28;8:356. doi: 10.1186/1752-1947-8-356.

29.

The risk of colorectal cancer in patients with ulcerative colitis.

Nowacki TM, Brückner M, Eveslage M, Tepasse P, Pott F, Thoennissen NH, Hengst K, Ross M, Bettenworth D.

Dig Dis Sci. 2015 Feb;60(2):492-501. doi: 10.1007/s10620-014-3373-2. Epub 2014 Oct 4.

PMID:
25280558
30.

Quantitative stain-free and continuous multimodal monitoring of wound healing in vitro with digital holographic microscopy.

Bettenworth D, Lenz P, Krausewitz P, Brückner M, Ketelhut S, Domagk D, Kemper B.

PLoS One. 2014 Sep 24;9(9):e107317. doi: 10.1371/journal.pone.0107317. eCollection 2014.

31.

Murine endoscopy for in vivo multimodal imaging of carcinogenesis and assessment of intestinal wound healing and inflammation.

Brückner M, Lenz P, Nowacki TM, Pott F, Foell D, Bettenworth D.

J Vis Exp. 2014 Aug 26;(90). doi: 10.3791/51875.

32.

Melanocortin 1 receptor-signaling deficiency results in an articular cartilage phenotype and accelerates pathogenesis of surgically induced murine osteoarthritis.

Lorenz J, Seebach E, Hackmayer G, Greth C, Bauer RJ, Kleinschmidt K, Bettenworth D, Böhm M, Grifka J, Grässel S.

PLoS One. 2014 Sep 5;9(9):e105858. doi: 10.1371/journal.pone.0105858. eCollection 2014.

33.

Immune suppression via glucocorticoid-stimulated monocytes: a novel mechanism to cope with inflammation.

Varga G, Ehrchen J, Brockhausen A, Weinhage T, Nippe N, Belz M, Tsianakas A, Ross M, Bettenworth D, Spieker T, Wolf M, Lippe R, Tenbrock K, Leenen PJ, Roth J, Sunderkötter C.

J Immunol. 2014 Aug 1;193(3):1090-9. doi: 10.4049/jimmunol.1300891. Epub 2014 Jul 2.

34.

Nicotinamide treatment ameliorates the course of experimental colitis mediated by enhanced neutrophil-specific antibacterial clearance.

Bettenworth D, Nowacki TM, Ross M, Kyme P, Schwammbach D, Kerstiens L, Thoennissen GB, Bokemeyer C, Hengst K, Berdel WE, Heidemann J, Thoennissen NH.

Mol Nutr Food Res. 2014 Jul;58(7):1474-90. doi: 10.1002/mnfr.201300818. Epub 2014 Apr 25.

PMID:
24764203
35.

[Prevalence and management of anemia in patients with inflammatory bowel disease].

Bettenworth D, Dignass A.

Z Gastroenterol. 2014 Apr;52(4):374-5. doi: 10.1055/s-0034-1366083. Epub 2014 Apr 9. German. No abstract available.

PMID:
24718943
36.

Regulated expression of leukocyte-specific transcript (LST) 1 in human intestinal inflammation.

Heidemann J, Kebschull M, Tepasse PR, Bettenworth D.

Inflamm Res. 2014 Jul;63(7):513-7. doi: 10.1007/s00011-014-0732-6. Epub 2014 Mar 30.

PMID:
24682411
37.

Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.

Bettenworth D, Rieder F.

Fibrogenesis Tissue Repair. 2014 Mar 29;7(1):5. doi: 10.1186/1755-1536-7-5.

38.

Crohn's disease complicated by intestinal infection with methicillin-resistant Staphylococcus aureus.

Bettenworth D, Nowacki TM, Friedrich A, Becker K, Wessling J, Heidemann J.

World J Gastroenterol. 2013 Jul 21;19(27):4418-21. doi: 10.3748/wjg.v19.i27.4418.

39.

Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation.

Bettenworth D, Reuter S, Hermann S, Weckesser M, Kerstiens L, Stratis A, Nowacki TM, Ross M, Lenze F, Edemir B, Maaser C, Pap T, Koschmieder S, Heidemann J, Schäfers M, Lügering A.

J Nucl Med. 2013 May;54(5):748-55. doi: 10.2967/jnumed.112.112623. Epub 2013 Mar 20.

40.

Digital holographic microscopy quantifies the degree of inflammation in experimental colitis.

Lenz P, Bettenworth D, Krausewitz P, Brückner M, Ketelhut S, von Bally G, Domagk D, Kemper B.

Integr Biol (Camb). 2013 Mar;5(3):624-30. doi: 10.1039/c2ib20227a.

PMID:
23328993
41.

Rare cause of upper gastrointestinal bleeding in a 27-year-old male patient.

Bettenworth D, Rijcken E, Müller KM, Mosch-Messerich A, Heidemann J.

Gut. 2012 Sep;61(9):1367. doi: 10.1136/gutjnl-2012-302034. Epub 2012 Mar 8. No abstract available.

PMID:
22403176
42.

Advanced-stage syphilis unmasking after immunomodulator therapy in a patient with ulcerative colitis.

Bettenworth D, Floer M, Krummenerl T, Wehrmann W, Schärer L, Heidemann J.

Am J Gastroenterol. 2012 Jan;107(1):144-5. doi: 10.1038/ajg.2011.330. No abstract available.

PMID:
22218040
43.

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease.

Nowacki TM, Bettenworth D, Ross M, Heidemann J, Lehmann PV, Lügering A.

Cells. 2012 Apr 23;1(2):35-50. doi: 10.3390/cells1020035.

44.

The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function.

Bettenworth D, Buyse M, Böhm M, Mennigen R, Czorniak I, Kannengiesser K, Brzoska T, Luger TA, Kucharzik T, Domschke W, Maaser C, Lügering A.

Am J Pathol. 2011 Sep;179(3):1230-42. doi: 10.1016/j.ajpath.2011.05.013. Epub 2011 Jul 8.

45.

A typical presentation of a rare cause of obscure gastrointestinal bleeding.

Reuter S, Bettenworth D, Mees ST, Neumann J, Beyna T, Domschke W, Wessling J, Ullerich H.

World J Gastrointest Endosc. 2011 Feb 16;3(2):40-5. doi: 10.4253/wjge.v3.i2.40.

46.

[Cerebral vasculitis as rare extraintestinal manifestation in ulcerative colitis: review of the literature and case report].

Bonrath EM, Rijcken E, Dziewas R, Vieth V, Bettenworth D, Senninger N, Brüwer M.

Zentralbl Chir. 2010 Aug;135(4):350-3. doi: 10.1055/s-0030-1247464. Epub 2010 Aug 30. Review. German. No abstract available.

PMID:
20806139
47.

Two coincident squamous cell carcinomas of the esophagus in a patient with achalasia: evidence by F-18 FDG PET/CT.

Bettenworth D, Reuter S, Fuchs M, Schnöckel U, Wessling J, Domschke W, Weckesser M, Domagk D.

Clin Nucl Med. 2010 Aug;35(8):646-8. doi: 10.1097/RLU.0b013e3181e4ddd9. No abstract available.

PMID:
20631527
48.

Incomplete tubular duplication of the esophagus becoming symptomatic in adulthood.

Lenz P, Wessling J, Foell D, Bettenworth D, Nowacki T, Ullerich H, Domschke W, Domagk D.

Endoscopy. 2009;41 Suppl 2:E114-5. doi: 10.1055/s-0029-1214631. Epub 2009 Jun 23. No abstract available.

PMID:
19551616

Supplemental Content

Loading ...
Support Center